The Cayman Islands government said Thursday it is working with a US biotech company called BioIntelliSense to use its health monitoring ‘BioButton’ device as part of Cayman’s phased border reopening plan.
When the first phase of Cayman’s border reopening begins on 1 Sept., travellers who have tested negative for COVID-19 three days prior to arriving on island can wear a BioButton and self-isolate at a residence of their choice for five days, or, if they choose not to wear the device, must quarantine at a government-managed facility for 14 days, officials said a press release.
Costs and quantities of the medical-grade sensors are yet to be determined.
Tourism Minister Moses Kirkconnell, in a media statement further outlining Cayman’s phased reopening plan, said the BioIntelliSense BioButton device monitors travellers’ heart rate at rest, respiratory rate and skin temperature to enable earlier detection of symptoms associated with COVID-19.
“This advanced health screening…